Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Clifford

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
The Journal of Antimicrobial Chemotherapy|January 22, 2013
Etravirine in CSF is highly protein boundAnh Nguyen, Steven Rossi, David Croteau, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 4, 2008
Ubiquitin proteasome-mediated synaptic reorganization: a novel mechanism underlying rapid ischemic toleranceRobert Meller, Simon John Thompson, Theresa Ann Lusardi, et al.
The Journal of Infectious Diseases|July 29, 2010
Effect of CYP2B6, ABCB1, and CYP3A5 polymorphisms on efavirenz pharmacokinetics and treatment response: an AIDS Clinical Trials Group studyHeather J Ribaudo, Huan Liu, Matthias Schwab, et al.
Antimicrobial Agents and Chemotherapy|September 30, 2010
Total raltegravir concentrations in cerebrospinal fluid exceed the 50-percent inhibitory concentration for wild-type HIV-1David Croteau, Scott Letendre, Brookie M Best, et al.
Journal of Clinical and Experimental Neuropsychology|January 14, 2011
Effects of traumatic brain injury on cognitive functioning and cerebral metabolites in HIV-infected individualsKenny Lin, Michael J Taylor, Robert Heaton, et al.
Journal of Neurovirology|March 29, 2008
Second assessment of NeuroAIDS in AfricaKevin Robertson, Kathy Kopnisky, James Hakim, et al.
Journal of Affective Disorders|July 26, 2011
Lifetime suicidal ideation and attempt are common among HIV+ individualsJayraan Badiee, David J Moore, J Hampton Atkinson, et al.
Journal of Neurovirology|August 26, 2016
Evaluating the accuracy of self-report for the diagnosis of HIV-associated neurocognitive disorder (HAND): defining "symptomatic" versus "asymptomatic" HANDLisa C Obermeit, Jessica Beltran, Kaitlin B Casaletto, et al.
AIDS Research and Human Retroviruses|March 4, 2016
The Effect of Chloroquine on Immune Activation and Interferon Signatures Associated with HIV-1Jeffrey M Jacobson, Steven E Bosinger, Minhee Kang, et al.
Annals of Neurology|September 24, 2022
Progressive Multifocal Leukoencephalopathy Treated by Immune Checkpoint InhibitorsXavier Boumaza, Baptiste Bonneau, Damien Roos-Weil, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
The Journal of Antimicrobial Chemotherapy|January 22, 2013
Etravirine in CSF is highly protein boundAnh Nguyen, Steven Rossi, David Croteau, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|January 4, 2008
Ubiquitin proteasome-mediated synaptic reorganization: a novel mechanism underlying rapid ischemic toleranceRobert Meller, Simon John Thompson, Theresa Ann Lusardi, et al.
The Journal of Infectious Diseases|July 29, 2010
Effect of CYP2B6, ABCB1, and CYP3A5 polymorphisms on efavirenz pharmacokinetics and treatment response: an AIDS Clinical Trials Group studyHeather J Ribaudo, Huan Liu, Matthias Schwab, et al.
Antimicrobial Agents and Chemotherapy|September 30, 2010
Total raltegravir concentrations in cerebrospinal fluid exceed the 50-percent inhibitory concentration for wild-type HIV-1David Croteau, Scott Letendre, Brookie M Best, et al.
Journal of Clinical and Experimental Neuropsychology|January 14, 2011
Effects of traumatic brain injury on cognitive functioning and cerebral metabolites in HIV-infected individualsKenny Lin, Michael J Taylor, Robert Heaton, et al.
Journal of Neurovirology|March 29, 2008
Second assessment of NeuroAIDS in AfricaKevin Robertson, Kathy Kopnisky, James Hakim, et al.
Journal of Affective Disorders|July 26, 2011
Lifetime suicidal ideation and attempt are common among HIV+ individualsJayraan Badiee, David J Moore, J Hampton Atkinson, et al.
Journal of Neurovirology|August 26, 2016
Evaluating the accuracy of self-report for the diagnosis of HIV-associated neurocognitive disorder (HAND): defining "symptomatic" versus "asymptomatic" HANDLisa C Obermeit, Jessica Beltran, Kaitlin B Casaletto, et al.
AIDS Research and Human Retroviruses|March 4, 2016
The Effect of Chloroquine on Immune Activation and Interferon Signatures Associated with HIV-1Jeffrey M Jacobson, Steven E Bosinger, Minhee Kang, et al.
Annals of Neurology|September 24, 2022
Progressive Multifocal Leukoencephalopathy Treated by Immune Checkpoint InhibitorsXavier Boumaza, Baptiste Bonneau, Damien Roos-Weil, et al.
Pageof 6